Skip to main content

Published locations for Cochrane review: Trastuzumab benefit outweighs harm for advanced HER2-positive breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Cochrane review: Trastuzumab benefit outweighs harm for advanced HER2-positive breast cancer

User login

  • Reset your password
  • /content/cochrane-review-trastuzumab-benefit-outweighs-harm-advanced-her2-positive-breast-cancer
  • /obgynnews/article/82953/breast-cancer/cochrane-review-trastuzumab-benefit-outweighs-harm-advanced
  • /oncologypractice/article/82953/breast-cancer/cochrane-review-trastuzumab-benefit-outweighs-harm
  • /obgyn/article/82953/breast-cancer/cochrane-review-trastuzumab-benefit-outweighs-harm-advanced-her2
  • /hematology-oncology/article/82953/breast-cancer/cochrane-review-trastuzumab-benefit-outweighs-harm
  • /breast-cancer-icymi/article/82953/breast-cancer/cochrane-review-trastuzumab-benefit-outweighs-harm